Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $19.17.
A number of equities analysts have weighed in on SBRA shares. Truist Financial cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and decreased their price objective for the company from $18.00 to $17.00 in a research report on Friday, January 17th. JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research note on Tuesday, January 7th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Finally, Mizuho reiterated a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research note on Thursday, December 5th.
Check Out Our Latest Stock Analysis on Sabra Health Care REIT
Institutional Inflows and Outflows
Sabra Health Care REIT Stock Up 1.2 %
NASDAQ SBRA opened at $16.81 on Thursday. The stock has a market cap of $4.00 billion, a PE ratio of 31.72, a P/E/G ratio of 1.97 and a beta of 1.25. The business has a 50 day moving average price of $16.77 and a two-hundred day moving average price of $17.63. Sabra Health Care REIT has a fifty-two week low of $13.31 and a fifty-two week high of $20.03. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88.
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last announced its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting the consensus estimate of $0.36. The business had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. As a group, sell-side analysts predict that Sabra Health Care REIT will post 1.45 EPS for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 7.14%. The ex-dividend date of this dividend was Friday, February 14th. Sabra Health Care REIT’s payout ratio is currently 226.42%.
Sabra Health Care REIT Company Profile
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also
- Five stocks we like better than Sabra Health Care REIT
- Where to Find Earnings Call Transcripts
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Manufacturing Stocks Investing
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How to Invest in the Best Canadian StocksĀ
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.